Is Avatrombopag/Suxin available in tablet form?

Avatrombopag/Avatrombopag is an oral thrombopoietin receptor agonist, mainly used to treat thrombocytopenia in patients with chronic liver disease. It promotes platelet production by inhibiting platelet precursor cells in the bone marrow, thereby effectively increasing platelet counts. This drug is particularly useful in patients who require invasive surgery or other medical procedures and whose platelet counts may not be low enough to be safe.

In clinical applications, avatrombopag is usually used in patients for whom traditional treatments are ineffective or intolerable. The active ingredient in avatrombopag is avatrombopag maleate. Its mechanism of action is to bind to the thrombopoietin receptor and activate downstream signaling pathways, thereby enhancing platelet production. As a new type of drug, the launch of avatrombopag provides a new treatment option for patients with thrombocytopenia caused by chronic liver disease, improving their quality of life and surgical safety.

Avatrombopag is mainly provided in the form of immediate-release tablets. Each tablet contains20 mg of avatrombopag. Its generic name is avatrombopag maleate tablets. This kind of tablet is a light yellow round double-sided convex film-coated tablet, with the word "AVA" engraved on one side and the word "20" engraved on the other side. It appears white or off-white after the coating is removed. When used by patients, it should be taken with food once a day for 5 consecutive days to ensure that the platelet count can rise to the target level before elective invasive examinations or surgeries.

There are also some potential risks and precautions when using avatrombopag. For example, TPO receptor agonists have been associated with thrombosis and thromboembolic complications in patients with chronic liver disease, so patients should be closely monitored for thromboembolic symptoms during use. Doctors will also pay attention to possible side effects of patients, including headache, nausea, fatigue, etc., to ensure the safety and effectiveness of treatment.